Another Biosimilar to Herceptin
The US Food and Drug Administration (FDA) has approved another biosimilar to a drug that treats breast, stomach and esophageal cancer.
Reducing Men's Cancer Risk
Everyday choices can play a significant role in your risk of cancer, regardless of your gender. Here are some specific steps men can take to reduce their cancer risk.
What You Need to Know for Men's Health Month
June is Men's Health Month. Read on to learn what you can do this month to lower your risk of prostate cancer.
Summer Sun Safety
Do you ever wonder why your parents always nagged you about putting on sunscreen? This summer, take some time to learn more about sun safety.
Breast Cancer Rx Now Approved for Men
A breast cancer medication that was previously approved for women can now be used to treat men with advanced breast cancer.
Another Biosimilar for a Common Breast Cancer Rx
The US Food and Drug Administration (FDA) has approved another biosimilar for a common breast cancer medication.
Colorectal Cancer FAQs
There will be 101,000 new cases of colon cancer and over 44,000 new cases of rectal cancer in the United States this year, the American Cancer Society (ACS) estimates. Here's what you need to know.
Company Under Fire for Illegal Screening Tool
Total Thermal Imaging, Inc., is in the hot seat for marketing and selling an unapproved product for detecting certain diseases.
Heated Tobacco Devices: Not a Safe Option
New heated tobacco devices are not a safe alternative to smoking traditional cigarettes or using electronic cigarettes, according to a new study.
A New Biosimilar for a Breast Cancer Rx
The US Food and Drug Administration (FDA) has approved the third Herceptin (trastuzumab) biosimilar to treat certain types of cancer.